Results 111 to 120 of about 29,788 (124)

Prognostic Factors for Recurrence After Conservative Treatment in a Series of 119 Patients With Stage I Serous Borderline Tumors of the Ovary

Annals of Oncology, 2014
Philippe Morice, Emile Daraï, Catherine Uzan   +2 more
exaly  

Minimal Uterine Serous Carcinoma: A Clinicopathological Study of 40 Cases

Modern Pathology, 2005
Pei Hui, Peter E Schwartz, Fattaneh A Tavassoli   +2 more
exaly  

Eplerenone for Chronic Central Serous Chorioretinopathy

Lancet, The, 2020
Giuseppe Querques, Enrico Borrelli, Riccardo Sacconi   +2 more
exaly  

Risk of Malignancy in Serous Cystic Neoplasms of the Pancreas

Digestion, 2003
Oliver Strobel, Waldemar Uhl, Kaspar Z'Graggen   +2 more
exaly  

Low-Grade Serous Ovarian Cancer: A Unique Disease

Current Oncology Reports, 2008
David Gershenson, Kathleen M. Schmeler
exaly  

The Diagnostic Utility of TP53 and CDKN2A to Distinguish Ovarian High-Grade Serous Carcinoma From Low-Grade Serous Ovarian Tumors

Modern Pathology, 2013
Alon D Altman, Martin Köbel, Gregg Nelson   +2 more
exaly  

Central Serous Chorioretinopathy and Glucocorticoids

Survey of Ophthalmology, 2002
Constantin J Pournaras
exaly  

High-Grade Ovarian Serous Carcinoma Exhibits Significantly Higher p16 Expression Than Low-Grade Serous Carcinoma and Serous Borderline Tumour

Histopathology, 2007
Michael T Deavers, W G McCluggage
exaly  

Transforming Treatment Paradigms: Focus on Personalized Medicine for High-Grade Serous Ovarian Cancer

Ca-A Cancer Journal for Clinicians
Ioana Braicu, Sylvia Mechsner, Paweł Kordowitzki   +2 more
exaly  

Comparison of the Clinical Behavior of Newly Diagnosed Stages II–IV Low-Grade Serous Carcinoma of the Ovary With That of Serous Ovarian Tumors of Low Malignant Potential That Recur as Low-Grade Serous Carcinoma

Gynecologic Oncology, 2007
Diane C. Bodurka, Anias Malpica, David Gershenson   +2 more
exaly